Institutional investors hold a majority ownership of EXAS through the 68.19% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2012, these large investors purchased a net $2.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LUTHER KING CAPITAL MANAGEMENT C... Bought 603.3 Thousand shares of Exact Sciences Corp
BLACKROCK FUND ADVISORS Bought 375.9 Thousand shares of Exact Sciences Corp